Anpario plc (LON:ANP – Get Free Report) insider Marc Wilson bought 3,778 shares of the stock in a transaction that occurred on Tuesday, April 1st. The shares were purchased at an average cost of GBX 398 ($5.21) per share, with a total value of £15,036.44 ($19,701.83).
Anpario Price Performance
Shares of LON ANP opened at GBX 351.50 ($4.61) on Friday. The company has a current ratio of 6.15, a quick ratio of 5.16 and a debt-to-equity ratio of 0.10. The firm’s 50-day moving average price is GBX 428.63 and its 200-day moving average price is GBX 377.29. The firm has a market capitalization of £59.97 million, a P/E ratio of 19.41 and a beta of 0.58. Anpario plc has a 1-year low of GBX 229.50 ($3.01) and a 1-year high of GBX 488.55 ($6.40).
Anpario (LON:ANP – Get Free Report) last posted its quarterly earnings results on Monday, March 31st. The company reported GBX 28.40 ($0.37) earnings per share for the quarter. Anpario had a return on equity of 8.74% and a net margin of 9.23%. Equities research analysts anticipate that Anpario plc will post 23.5757801 earnings per share for the current fiscal year.
Anpario Increases Dividend
Analyst Ratings Changes
Several research analysts have recently weighed in on the company. Canaccord Genuity Group lifted their price objective on Anpario from GBX 380 ($4.98) to GBX 500 ($6.55) and gave the stock a “buy” rating in a research report on Tuesday, January 14th. Shore Capital reiterated a “house stock” rating on shares of Anpario in a report on Monday.
Check Out Our Latest Stock Report on ANP
About Anpario
Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.
Further Reading
- Five stocks we like better than Anpario
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Shares of RH Down Nearly 40%: Where Investors Can Turn To Now
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Tariffs, Spin-Out, and R2 Updates Are Positive Signs for Rivian
- What is the Dogs of the Dow Strategy? Overview and Examples
- Cathie Wood Loads Up on Baidu—Is It the Right Time to Buy?
Receive News & Ratings for Anpario Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anpario and related companies with MarketBeat.com's FREE daily email newsletter.